Fortress Biotech, Inc. (FBIO) stock prices updated...
 

Fortress Biotech, Inc. stock price

Fortress Biotech, Inc. latest news:


  • 12/11/2017 15:31:48

    BRIEF-Mustang Bio's Mb-102 Car T Therapy Achieves Complete Response In Phase 1 Clinical Trial

    Fortress Biotech Inc(FBIO): * MUSTANG BIO'S MB-102 CAR T THERAPY ACHIEVES COMPLETE RESPONSE IN ACUTE MYELOID LEUKEMIA AND BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM IN PHASE 1 CLINICAL TRIAL. * MUSTANG BIO - INVESTIGATORS FOUND INFUSIONS OF MB-102 ARE SAFE AND WELL TOLERATED. * MUSTANG BIO - CAR T THERAPY IS SAFE, WELL TOLERATED Source text for Eikon: Further company coverage:

  • More trends:

    Forward Air CorporationFWRD | Forward Industries, Inc.FORD | Forward Pharma A/SFWP | Fossil Group, Inc.FOSL | Foundation Medicine, Inc.FMI | Fox Chase Bancorp, Inc.FXCB | Fox Factory Holding Corp.FOXF | Francesca's Holdings CorporationFRAN | Franklin Electric Co., Inc.FELE | Fred's, Inc.FRED |